{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:13:38Z","timestamp":1779257618567,"version":"3.51.4"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["no.82160582"],"award-info":[{"award-number":["no.82160582"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Triple-negative breast cancer (TNBC) has poor prognosis, largely due to its high rates of metastasis and recurrence. Anoikis plays a pivotal role in tumor metastasis; however, its role in TNBC remains elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Cox regression analysis was performed on anoikis-related genes (ARGs) to develop a prognostic signature. A clinical nomogram was developed based on the prognostic signatures. Associations of the signature with the immunogenomic landscape and response to targeted therapy and immunotherapy were assessed. Key prognostic genes were identified using random survival forest analysis. To evaluate Cell cycle and apoptosis regulator 2 (CCAR2) expression and its independent prognostic role, we performed RT-qPCR, immunohistochemistry, Kaplan-Meier analysis, and multivariate Cox regression analysis.\n                      <jats:italic>In vitro<\/jats:italic>\n                      functional experiments were conducted to assess the effect of CCAR2 on anoikis, migration, invasion, and stemness. Bioinformatics analyses were utilized to evaluate the association between CCAR2 expression and the immunological landscape and immunotherapy response.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A six-gene prognostic signature based on ARGs was constructed, stratifying patients into high- and low-risk groups with a significant difference in overall survival. The nomogram achieved good calibration and strong discriminatory accuracy. Additionally, the signature showed significant correlations with the immunogenomic landscape and predicted the response to both targeted therapy and immunotherapy. Random survival forest analysis identified CCAR2 as a key gene. In TNBC, upregulation of CCAR2 independently predicted a higher histological grade, metastasis, and poor overall survival. Its knockdown inhibits cell migration and invasion, suppresses stemness, and induces anoikis. Furthermore, CCAR2 is associated with an immunosuppressive tumor microenvironment in basal-like TNBC, fostering an immune-evasive phenotype that correlates with a poorer predicted response to immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We constructed an ARG-based prognostic signature for TNBC and identified CCAR2 as a key metastatic driver that confers anoikis resistance, immune evasion, and stemness. These findings may advance the prognostic stratification of TNBC and could highlight CCAR2 as a potential therapeutic target for TNBC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1808490","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:45:52Z","timestamp":1779255952000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[{"name":"College of Clinical Medicine, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingwang","family":"Lu","sequence":"additional","affiliation":[{"name":"College of Clinical Medicine, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luying","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Basic Medicine, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunkang","family":"Li","sequence":"additional","affiliation":[{"name":"College of Clinical Medicine, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilin","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Basic Medicine, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Luo","sequence":"additional","affiliation":[{"name":"College of Clinical Medicine, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Pan","sequence":"additional","affiliation":[{"name":"College of Clinical Medicine, Dali University","place":["Dali, Yunnan, China"]},{"name":"Department of Pathology, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Gao","sequence":"additional","affiliation":[{"name":"College of Clinical Medicine, Dali University","place":["Dali, Yunnan, China"]},{"name":"Department of Pathology, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2013-0953-SA","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"138","author":"Wolff","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.25.6529","article-title":"American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230034","article-title":"Triple-negative breast cancer: Histopathologic features, genomics, and treatment","volume":"43","author":"Adrada","year":"2023","journal-title":"Radiographics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_543_17","article-title":"Clinicopathological features and prognostic evaluation of bone metastasis in triple-negative breast cancer","volume":"13","author":"Luo","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.124.4.619","article-title":"Disruption of epithelial cell-matrix interactions induces apoptosis","volume":"124","author":"Frisch","year":"1994","journal-title":"J Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/path.3000","article-title":"Anoikis: an emerging hallmark in health and diseases","volume":"226","author":"Taddei","year":"2012","journal-title":"J Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.05.029","article-title":"Anoikis resistance and tumor metastasis","volume":"272","author":"Simpson","year":"2008","journal-title":"Cancer Lett"},{"key":"B9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13046-023-02835-6","article-title":"Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1\u03b1 promotes invasion and metastasis of nasopharyngeal carcinoma","volume":"42","author":"Liao","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-021-10139-2","article-title":"Interconnected high-dimensional landscapes of epithelial-mesenchymal plasticity and stemness in cancer","volume":"39","author":"Sahoo","year":"2022","journal-title":"Clin Exp Metastasis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1245421","article-title":"Cancer stem cell-immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet","volume":"14","author":"Guha","year":"2023","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13287-025-04218-4","article-title":"The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials","volume":"16","author":"Zhang","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01960-4","article-title":"The complexity of immune evasion mechanisms throughout the metastatic cascade","volume":"25","author":"Haynes","year":"2024","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.11.006","article-title":"A clinician\u2019s guide to bioinformatics for next-generation sequencing","volume":"18","author":"Larson","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000003254","article-title":"Bioinformatics tools and resources for cancer and application","volume":"137","author":"Huang","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/s1359-6446(04)03224-6","article-title":"Bioinformatics and cancer target discovery","volume":"9","author":"Desany","year":"2004","journal-title":"Drug Discov Today"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1125782","article-title":"Anoikis-related genes combined with single cell sequencing: Insights into model specification of lung adenocarcinoma and applicability for prognosis and therapy","volume":"11","author":"Zhou","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14766","article-title":"Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma","volume":"14","author":"Diao","year":"2023","journal-title":"Thorac Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05157-4","article-title":"Comprehensive analysis of anoikis-related genes in prognosis and immune infiltration of gastric cancer based on bulk and single-cell RNA sequencing data","volume":"149","author":"Yang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1049\/syb2.12088","article-title":"Anoikis-related genes as potential prognostic biomarkers in gastric cancer: A multilevel integrative analysis and predictive therapeutic value","volume":"18","author":"Lin","year":"2024","journal-title":"IET Syst Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1232814","article-title":"Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1158605","article-title":"An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"11525","DOI":"10.1038\/s41598-024-62370-y","article-title":"Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction","volume":"14","author":"Ding","year":"2024","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/cji.0000000000000523","article-title":"Prognostic value and immune signatures of anoikis-related genes in breast cancer","volume":"47","author":"Wu","year":"2024","journal-title":"J Immunother"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241288118","article-title":"Identification of novel anoikis-related gene signatures to predict the prognosis, immune microenvironment, and drug sensitivity of breast cancer patients","volume":"31","author":"Liu","year":"2024","journal-title":"Cancer Control"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2025.101947","article-title":"Exploration of the role of drug resistance-associated anoikis-related genes in HER2-negative breast cancer through bioinformatics analysis","volume":"41","author":"Wu","year":"2025","journal-title":"Biochem Biophys Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.212516099","article-title":"DBC2, a candidate for a tumor suppressor gene involved in breast cancer","volume":"99","author":"Hamaguchi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14579","article-title":"CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis","volume":"111","author":"Johnson","year":"2020","journal-title":"Cancer Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41419-018-0899-9","article-title":"DBC1 regulates Wnt\/\u03b2-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer","volume":"9","author":"Kim","year":"2018","journal-title":"Cell Death Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.10.134","article-title":"Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma","volume":"494","author":"Li","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11013","article-title":"Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions","volume":"7","author":"Pinho","year":"2016","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066975","article-title":"The expression of SIRT1 and DBC1 in laryngeal and hypopharyngeal carcinomas","volume":"8","author":"Yu","year":"2013","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.09.033","article-title":"ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src\/FAK signaling in hepatocellular carcinoma","volume":"442","author":"Li","year":"2019","journal-title":"Cancer Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf388","article-title":"TIMER3: an enhanced resource for tumor immune analysis","volume":"53","author":"Cui","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa176","article-title":"Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response","volume":"22","author":"Hu","year":"2021","journal-title":"Brief Bioinform"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101099","article-title":"Targeting anoikis resistance as a strategy for cancer therapy","volume":"75","author":"Wang","year":"2024","journal-title":"Drug Resist Update"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-18-1177","article-title":"Insights into molecular classifications of triple-negative breast cancer: Improving patient selection for treatment","volume":"9","author":"Garrido-Castro","year":"2019","journal-title":"Cancer Discov"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1149193","article-title":"Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer","volume":"13","author":"Lu","year":"2023","journal-title":"Front Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00018-023-04688-w","article-title":"Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer","volume":"80","author":"Zou","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1038\/s41598-023-31186-7","article-title":"Fluorouracil exacerbates alpha-crystallin B chain-mediated cell migration in triple-negative breast cancer cell lines","volume":"13","author":"Yang","year":"2023","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2018.10.019","article-title":"In vivo \u03b2-catenin attenuation by the integrin \u03b15-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis","volume":"188","author":"Li","year":"2019","journal-title":"Biomaterials"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.12104","article-title":"The role of thrombomodulin in modulating ITGB3 expression and its implications for triple-negative breast cancer progression","volume":"48","author":"Chang","year":"2024","journal-title":"Cell Biol Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz133","article-title":"Targeting the PI3-kinase pathway in triple-negative breast cancer","volume":"30","author":"Pascual","year":"2019","journal-title":"Ann Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.smim.2016.01.001","article-title":"Combining targeted therapy with immunotherapy. Can 1 + 1 equal more than 2","volume":"28","author":"Robert","year":"2016","journal-title":"Semin Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01058-1","article-title":"Mechanistic insights into the dual role of CCAR2\/DBC1 in cancer","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2010.05.023","article-title":"Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma","volume":"42","author":"Lee","year":"2011","journal-title":"Hum Pathol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81247","article-title":"Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression","volume":"11","author":"Liu","year":"2022","journal-title":"Elife"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.01.066","article-title":"DBC1 functions as a tumor suppressor by regulating p53 stability","volume":"10","author":"Qin","year":"2015","journal-title":"Cell Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.4007","article-title":"DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-\u03baB activity","volume":"34","author":"Huan","year":"2015","journal-title":"Oncol Rep"},{"key":"B53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1615\/CritRevOncog.2018029433","article-title":"Cancer stem cells, their microenvironment and anoikis","volume":"24","author":"Ayla","year":"2019","journal-title":"Crit Rev Oncog"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25527","article-title":"Cancer stem cells protect non-stem cells from anoikis: Bystander effects","volume":"117","author":"Kim","year":"2016","journal-title":"J Cell Biochem"},{"key":"B55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41568-024-00760-0","article-title":"Stemness in solid Malignancies: coping with immune attack","volume":"25","author":"Agudo","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1818210116","article-title":"Cancer stemness, intratumoral heterogeneity, and immune response across cancers","volume":"116","author":"Miranda","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.08.002","article-title":"Immunomodulation by endothelial cells: prospects for cancer therapy","volume":"10","author":"Alnaqbi","year":"2024","journal-title":"Trends Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2023.11.002","article-title":"Reprogramming endothelial cells to empower cancer immunotherapy","volume":"30","author":"Abigail","year":"2024","journal-title":"Trends Mol Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-022-09862-5","article-title":"Endothelial Rap1B mediates T-cell exclusion to promote tumor growth: a novel mechanism underlying vascular immunosuppression","volume":"26","author":"Guru","year":"2023","journal-title":"Angiogenesis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1808490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:45:54Z","timestamp":1779255954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1808490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2026.1808490"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1808490","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"1808490"}}